{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:38:21Z","timestamp":1787315901151,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171062"],"award-info":[{"award-number":["82171062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301222"],"award-info":[{"award-number":["82301222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U2267220"],"award-info":[{"award-number":["U2267220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbrc.2025.152169","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:08:51Z","timestamp":1749236931000},"page":"152169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model"],"prefix":"10.1016","volume":"775","author":[{"given":"Shiyue","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4033-7399","authenticated-orcid":false,"given":"Yingying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbrc.2025.152169_bib1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152169_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2008.10.001","article-title":"Molecular pathology of age-related macular degeneration","volume":"28","author":"Ding","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152169_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-Year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2025.152169_bib4","article-title":"Imaging hyperreflective foci as an inflammatory biomarker after Anti-VEGF treatment in neovascular age-related macular degeneration patients with optical coherence tomography angiography","volume":"2021","author":"Wu","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"14","key":"10.1016\/j.bbrc.2025.152169_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152169_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152169_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1167\/iovs.18-25189","article-title":"Identification and quantification of the angiofibrotic switch in neovascular AMD","volume":"60","author":"Roberts","year":"2019","journal-title":"Invest. Ophthalmol. Vis Sci. Jan."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152169_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MNH.0b013e328344c3d4","article-title":"Mechanisms of fibrosis: the role of the pericyte","volume":"20","author":"Schrimpf","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbrc.2025.152169_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","article-title":"Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation","volume":"38","author":"Little","year":"2018","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib10","first-page":"855","article-title":"Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes","volume":"37","author":"Lopez","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152169_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ophtha.2017.08.019","article-title":"Clinicopathologic correlation of anti-vascular endothelial growth factor-treated type 3 neovascularization in age-related macular degeneration","volume":"125","author":"Li","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2025.152169_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","volume":"142","author":"Ishikawa","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152169_bib13","first-page":"21","article-title":"EMT and EndMT: emerging roles in age-related macular degeneration","volume":"16","author":"Shu","year":"2020","journal-title":"Int. J. Mol Sci. Jun."},{"key":"10.1016\/j.bbrc.2025.152169_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100969","article-title":"The retinal pigment epithelium: development, injury responses, and regenerative potential in Mammalian and non-mammalian systems","volume":"85","author":"George","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2025.152169_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fcell.2020.00501","article-title":"Role of epithelial-mesenchymal transition in retinal pigment epithelium dysfunction","volume":"8","author":"Zhou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152169_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108258","article-title":"The microRNAs miR-302d and miR-93 inhibit TGFB-mediated EMT and VEGFA secretion from ARPE-19 cells","volume":"201","author":"Fuchs","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1566524018666181004115304","article-title":"VEGFR2 and VEGF-C suppresses the epithelial-mesenchymal transition via YAP in retinal pigment epithelial cells","volume":"18","author":"Du","year":"2018","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152169_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"26","key":"10.1016\/j.bbrc.2025.152169_bib20","doi-asserted-by":"crossref","first-page":"22098","DOI":"10.18632\/oncotarget.4300","article-title":"Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.152169_bib21","article-title":"Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model","volume":"14","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152169_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1042\/CS20190249","article-title":"Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases","volume":"28","author":"Liu","year":"2019","journal-title":"Clin Sci (Lond). Jun"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152169_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel mechanisms for the antifibrotic action of nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.152169_bib24","first-page":"789","article-title":"Nintedanib inhibits TGF-\u03b2-induced myofibroblast transdifferentiation in human Tenon's fibroblasts","volume":"24","author":"Lin","year":"2018","journal-title":"Mol. Vis."},{"issue":"13","key":"10.1016\/j.bbrc.2025.152169_bib25","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1167\/iovs.15-17146","article-title":"BIBF1120 (Vargatef) inhibits preretinal neovascularization and enhances normal vascularization in a model of vasoproliferative retinopathy","volume":"56","author":"Rivera","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152169_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218632","article-title":"Inhibitory effect of nintedanib on VEGF secretion in retinal pigment epithelial cells induced by exposure to a necrotic cell lysate","volume":"14","author":"Hatano","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbrc.2025.152169_bib27","article-title":"RO4929097, a selective \u03b3-Secretase inhibitor, inhibits subretinal fibrosis via suppressing notch and ERK1\/2 signaling in laser-induced mouse model","volume":"1","author":"Zhang","year":"2022","journal-title":"Invest Ophthalmol Vis Sci. Sep"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152169_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/ceo.13619","article-title":"Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin","volume":"47","author":"Zhang","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152169_bib29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2741\/e481","article-title":"A modified histoimmunochemistry-assisted method for in situ RPE evaluation","volume":"4","author":"Zhang","year":"2012","journal-title":"Front Biosci. (Elite Ed). Jan"},{"key":"10.1016\/j.bbrc.2025.152169_bib30","first-page":"484","article-title":"Regulation of fibrotic signalling by TGF-\u03b2 receptor tyrosine phosphorylation","volume":"10","author":"Allison","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2025.152169_bib31","first-page":"17","article-title":"IPF, comorbidities and management implications","volume":"32","author":"Vancheri","year":"2015","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"22","key":"10.1016\/j.bbrc.2025.152169_bib32","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/14656566.2014.897695","article-title":"Nintedanib for the treatment of non-small-cell lung cancer","volume":"15","author":"Rashdan","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib34","first-page":"575","article-title":"Nintedanib: a review in fibrotic interstitial lung diseases","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs (Basel)"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152169_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15569527.2021.2016804","article-title":"Investigation of effect of nintedanib in experimental uveitis model","volume":"41","author":"Y\u0131ld\u0131r\u0131m","year":"2022","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.bbrc.2025.152169_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109431","article-title":"The anti-scar effect of tyrosine-kinase inhibitor nintedanib in experimental glaucoma filtration surgery in rabbits","volume":"229","author":"Y\u00fcksel","year":"2023","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152169_bib37","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/02713683.2022.2129071","article-title":"Effect of nintedanib nanothermoreversible hydrogel on neovascularization in an ocular alkali burn Rat model","volume":"47","author":"Liu","year":"2022","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbrc.2025.152169_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115403","article-title":"Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells","volume":"166","author":"Yin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152169_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114543","article-title":"Nintedanib prevents TGF-\u03b22-induced epithelial-mesenchymal transition in retinal pigment epithelial cells","volume":"161","author":"Yin","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152169_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40259-016-0194-1","article-title":"Targeting neovasculature with multitargeted antiangiogenesis tyrosine kinase inhibitors in non-small cell lung cancer","volume":"30","author":"Skouras","year":"2016","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152169_bib41","first-page":"Cd007930","article-title":"Angiogenesis inhibitors for the treatment of ovarian cancer","author":"Gaitskell","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152169_bib42","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1158\/1535-7163.MCT-18-0489","article-title":"Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models","volume":"17","author":"Awasthi","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.bbrc.2025.152169_bib43","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","article-title":"Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis","volume":"76","author":"Huang","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152169_bib44","first-page":"18","article-title":"TGF-\u03b2-Induced endothelial-mesenchymal transition in fibrotic diseases","volume":"17","author":"Pardali","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152169_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102817","article-title":"Nintedanib abrogates patient vitreous-induced Akt activation and tube formation of human retinal microvascular endothelial cells","volume":"94","author":"Li","year":"2025","journal-title":"Tissue Cell"},{"issue":"9","key":"10.1016\/j.bbrc.2025.152169_bib46","first-page":"484","article-title":"Fibrosis: regulation of fibrotic signalling by TGF-\u03b2 receptor tyrosine phosphorylation","volume":"10","author":"Allison","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152169_bib47","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","article-title":"Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion","volume":"67","author":"Galliher","year":"2007","journal-title":"Cancer Res. Apr"},{"issue":"11","key":"10.1016\/j.bbrc.2025.152169_bib48","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/jcmm.13206","article-title":"Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway","volume":"21","author":"Li","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152169_bib49","first-page":"24","article-title":"Nintedanib-\u03b1V\u03b26 Integrin ligand conjugates reduce TGF\u03b2-Induced EMT in human non-small cell lung cancer","volume":"12","author":"Andreucci","year":"2023","journal-title":"Int J Mol Sci. Jan"},{"issue":"Pt A","key":"10.1016\/j.bbrc.2025.152169_bib50","article-title":"Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK\/ERK\/S100A4 signalling pathway","volume":"113","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152169_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10439-009-9844-5","article-title":"bFGF and PDGF-BB for tendon repair: controlled release and biologic activity by tendon fibroblasts in vitro","volume":"38","author":"Thomopoulos","year":"2010","journal-title":"Ann. Biomed. Eng."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25008848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25008848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:02:15Z","timestamp":1751947335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25008848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S0006291X25008848"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152169","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152169"}}